Taurolidine line locks

Both ESPEN (European Society for Clinical Nutrition and Metabolism), and BIFA (British Intestinal Failure Alliance) recommend the use of taurolidine line locks:

ESPEN published guidelines on home parenteral nutrition in 2020.(1) Taurolidine locking is recommended as an additional strategy to prevent catheter related blood stream infections (CRBSIs) due to its favourable adverse event and cost profile.

BIFA also published guidelines in 2019 for the management of catheter related bloodstream infections.(2) These guidelines recommend consideration of the use of a prophylactic antimicrobial lock (e.g. taurolidine) for recurrent CRBSIs.

Calea are the UK distributor for TauroSept. TauroSept is a class III medical device containing taurolidine 2% solution.(3)

Calea can also supply other taurolidine containing catheter lock solutions. For more information please contact your local Calea Business Development Manager.

 

TauroSept is tough enough for prevention and treatment of catheter related infections

Taurosept is the only taurolidine containing line lock in the UK that can be used for prevention and treatment of catheter related infections.(3) To find out more, visit www.taurosept.co.uk  

Taurosept packaging
  1. Pironi L, Boeykens K, Bozzetti F, Joly F, Klek S, Lal S, Lichota M, Mühlebach S, Van Gossum A, Wanten G, Wheatley C, Bischoff SC. ESPEN guideline on home parenteral nutrition. Clin Nutr. 2020 Jun;39(6):1645-1666.
  2. British Intestinal Failure Alliance (BIFA). Management of Catheter Related Blood Stream Infections. January 2019. 
  3. TauroSept Instructions for Use. Geistlich Pharma AG. August 2023.
GB-HPN-2400062 November 2024